Expert guidance on overall management of liver cancer during the COVID-19
10.3760/cma.j.cn115610-20220507-00257
- VernacularTitle:新型冠状病毒肺炎疫情期间肝癌患者全程管理专家指导意见
- Author:
Huichuan SUN
1
;
Xinrong YANG
;
Zhiping YAN
;
Zhenggang REN
;
Rong LIU
;
Lan ZHANG
;
Yang XU
;
Yifeng HE
;
Zihan ZHANG
;
Jia FAN
;
Jian ZHOU
Author Information
1. 复旦大学附属中山医院肝脏外科 肝癌研究所，上海 200032
- Keywords:
Corona Virus Disease 2019;
Liver neoplasms, primary;
Surgical treatment;
Interventional therapy;
Systemic therapy;
Overall management
- From:
Chinese Journal of Digestive Surgery
2022;21(5):557-563
- CountryChina
- Language:Chinese
-
Abstract:
The pandemic of Corona Virus Disease 2019 (COVID-19) continues, which shows the concentrated or sporadic cases in multiple places. Current COVID situation is still complex. During the COVID-19, routine diagnosis and treatment of liver cancer patients has been affected in different degrees. Under the premise of following the treatment guidelines, how to reduce the risk of infection of patients and medical staff, utilize limited medical resources to maximally ensure anti-tumor treatment and related emergency treatment, and help patients get through the epidemic period is a problem for liver oncologists. Thus, experts of liver cancer treatment related disciplines of Zhongshan Hospital, Fudan University have written the Expert guidance on overall management of liver cancer during the COVID-19, which aims to provide references for liver oncolo-gists to conduct clinical work safely and effectively under the epidemic prevention and control, and to help patients fight against the epidemic smoothly.
